Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1251582

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1251582

Global Bioprocess Validation Market Size study&Forecast, byTest Type by Process Component, by End-user and Regional Analysis, 2022-2029

PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Bioprocess Validation Market is valued at approximately USD 376.9 million in 2021 and is anticipated to grow with a healthy growth rate of more than 9.10% over the forecast period 2022-2029.Various actions that take place during the whole manufacturing cycle of a bioproduct are included in the bioprocess validation process.To maintain the quality, safety, and effectiveness of bioproducts, precise data are gathered, reviewed, and documented for every production phase. Strict regulatory standards for the manufacturing of safe and high-quality vaccines and pharmaceutical goods are driving the industry.The industry is boosted by the growing cooperation among the major market players for product launches. COVID-19, however, has had a favourable effect on the worldwide bioprocess validation market.

The COVID-19 standard had a significant impact on the bioprocess validation market since it's essential to validate bioprocesses at every step of medication development to check precision, effectiveness, and safety.There was an increasing need for medicines and vaccines to address the new SARS-CoV-2 virus. This prompted the major industry players to merge, work together, and make acquisitions in order to provide goods that were safe and compliant with FDA and cGMP regulations.The Food and Drug Administration (FDA) Drug Recall Statistics report from 2021 estimates that worldwide drug recalls total 1,279 each year. Another two key drivers driving the market's expansion are the rising demand for particular types of tests in R&D activities and the expanding trend of outsourcing laboratory testing services. In response to the rising trend of outsourcing laboratory testing services, businesses are growing their market share by providing a variety of services and solutions.However, it is anticipated that problems with extractables and leachable will impede market expansion.

The key regions considered for the Global Bioprocess ValidationMarketstudy includes Asia Pacific, North America, Europe, Latin America, and Rest of the World.North America is dominating the market share with a CAGR of 4.9%. This is a result of the significant outsourcing services being present in this area.Furthermore, there are numerous biopharmaceutical and biotechnology industries in North America that have received FDA approval. The American government has also increased the amount it spends on validation services.According to the prediction, the bioprocess validation market would experience the quickest growth in the Asia Pacific region in the coming years. This is because there is more knowledge regarding the advantages of vaccines, which results in more funding, improvements, and developments.

Major market players included in this report are:

  • Merck KGaA
  • Eurofins Scientific
  • Sartorius Stedim biotech SA
  • Pall Corporation
  • Cobetter Filtration Equipments Co., Ltd
  • Toxikon Corporation
  • Thermo Fisher Scientific
  • Almac Group
  • Danher Corporation
  • Meissner Filtration Products, INC

Recent Developments in the Market:

  • In May 2022, a new informational resource for the bioprocess industry, the Bioprocess Resource Center, was created by Qosina.
  • In January 2022, complete acquisition of PeproTech, a pioneer in recombinant proteins, by Thermo Fisher Scientific.
  • In December 2021, In order to give customers a complete freeze-thaw solution, Sartorius and HOF Sonderanlagenbau entered into cooperation in December 2021 to merge two HOF horizontal plate freeze-thaw units into Sartorius' portfolio.

Global Bioprocess Validation Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Test Type, Process Component, End-user, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Test End-user offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test Type:

  • Extractables Testing Services
  • Microbiological Testing Services
  • Physiochemical Testing Services
  • Integrity Testing Services
  • Compatibility Testing Services
  • Other Testing Services

By Process Component:

  • Filter Elements
  • Media containers and bags
  • Freezing and Thawing Process Bags
  • Mixing Systems
  • Bioreactors
  • Transfer Systems
  • Other

By End-user:

  • PharmaceuticalCompanies
  • Biotechnology Companies
  • Contract Development& Manufacturing Organizations
  • Other

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Bioprocess Validation Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Bioprocess Validation Market, by Test Type, 2019-2029 (USD Million)
    • 1.2.3. Bioprocess Validation Market, by Process Component, 2019-2029 (USD Million)
    • 1.2.4. Bioprocess Validation Market, by End-user, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Bioprocess Validation Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Bioprocess Validation Market Dynamics

  • 3.1. Bioprocess Validation Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing Collaboration among key market players
      • 3.1.1.2. Positive Impact of COVID-19
    • 3.1.2. Market Challenges
      • 3.1.2.1. Problems with Extractables and Leachable
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rise in R&D Expenditure.
      • 3.1.3.2. Growing need for outsourcing bioprocess validation

Chapter 4. Global Bioprocess Validation Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Bioprocess Validation Market, by Test Type

  • 6.1. Market Snapshot
  • 6.2. Global Bioprocess Validation Market by Test Type, Performance - Potential Analysis
  • 6.3. Global Bioprocess Validation Market Estimates & Forecasts by Test Type 2019-2029 (USD Million)
  • 6.4. Bioprocess Validation Market, Sub Segment Analysis
    • 6.4.1. Extractables Testing Services
    • 6.4.2. Microbiological Testing Services
    • 6.4.3. Physiochemical Testing Services
    • 6.4.4. Integrity Testing Services
    • 6.4.5. Compatibility Testing Services
    • 6.4.6. Other Testing Services

Chapter 7. Global Bioprocess Validation Market, by Process Component

  • 7.1. Market Snapshot
  • 7.2. Global Bioprocess Validation Market by Process Component, Performance - Potential Analysis
  • 7.3. Global Bioprocess Validation Market Estimates & Forecasts by Process Component 2019-2029 (USD Million)
  • 7.4. Bioprocess Validation Market, Sub Segment Analysis
    • 7.4.1. Filter Elements
    • 7.4.2. Media containers and bags
    • 7.4.3. Freezing and Thawing Process Bags
    • 7.4.4. Mixing Systems
    • 7.4.5. Bioreactors
    • 7.4.6. Transfer Systems
    • 7.4.7. Other

Chapter 8. Global Bioprocess Validation Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global Bioprocess Validation Market by End-user, Performance - Potential Analysis
  • 8.3. Global Bioprocess Validation Market Estimates & Forecasts by End-user2019-2029 (USD Million)
  • 8.4. Bioprocess Validation Market, Sub Segment Analysis
    • 8.4.1. Pharmaceutical Companies
    • 8.4.2. Biotechnology Companies
    • 8.4.3. Contract Development & Manufacturing Organizations
    • 8.4.4. Other

Chapter 9. Global Bioprocess Validation Market, Regional Analysis

  • 9.1. Bioprocess Validation Market, Regional Market Snapshot
  • 9.2. North America Bioprocess Validation Market
    • 9.2.1. U.S. Bioprocess Validation Market
      • 9.2.1.1. Test Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Process Component breakdown estimates & forecasts,2019-2029
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Bioprocess Validation Market
  • 9.3. Europe Bioprocess Validation Market Snapshot
    • 9.3.1. U.K. Bioprocess Validation Market
    • 9.3.2. Germany Bioprocess Validation Market
    • 9.3.3. France Bioprocess Validation Market
    • 9.3.4. Spain Bioprocess Validation Market
    • 9.3.5. Italy Bioprocess Validation Market
    • 9.3.6. Rest of Europe Bioprocess Validation Market
  • 9.4. Asia-Pacific Bioprocess Validation Market Snapshot
    • 9.4.1. China Bioprocess Validation Market
    • 9.4.2. India Bioprocess Validation Market
    • 9.4.3. Japan Bioprocess Validation Market
    • 9.4.4. Australia Bioprocess Validation Market
    • 9.4.5. South Korea Bioprocess Validation Market
    • 9.4.6. Rest of Asia Pacific Bioprocess Validation Market
  • 9.5. Latin America Bioprocess Validation Market Snapshot
    • 9.5.1. Brazil Bioprocess Validation Market
    • 9.5.2. Mexico Bioprocess Validation Market
  • 9.6. Rest of The World Bioprocess Validation Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Merck KGaA
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Eurofins Scientific
    • 10.2.3. Sartorius Stedim biotech SA
    • 10.2.4. Pall Corporation
    • 10.2.5. Cobetter Filtration Equipments Co., Ltd
    • 10.2.6. Toxikon Corporation
    • 10.2.7. Thermo Fisher Scientific
    • 10.2.8. Almac Group
    • 10.2.9. Danher Corporation
    • 10.2.10. Meissner Filtration Products, INC

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Bioprocess Validation Market, report scope
  • TABLE 2. Global Bioprocess Validation Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Bioprocess Validation Market estimates & forecasts by Test Type 2019-2029 (USD Million)
  • TABLE 4. Global Bioprocess Validation Market estimates & forecasts by Process Component 2019-2029 (USD Million)
  • TABLE 5. Global Bioprocess Validation Market estimates & forecasts by End-user 2019-2029 (USD Million)
  • TABLE 6. Global Bioprocess Validation Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Bioprocess Validation Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Bioprocess Validation Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Bioprocess Validation Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Bioprocess Validation Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Bioprocess Validation Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Bioprocess Validation Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Bioprocess Validation Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Bioprocess Validation Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Bioprocess Validation Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row Bioprocess Validation Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row Bioprocess Validation Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Bioprocess Validation Market
  • TABLE 71. List of primary sources, used in the study of global Bioprocess Validation Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Bioprocess Validation Market, research methodology
  • FIG 2. Global Bioprocess Validation Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Bioprocess Validation Market, key trends 2021
  • FIG 5. Global Bioprocess Validation Market, growth prospects 2022-2029
  • FIG 6. Global Bioprocess Validation Market, porters 5 force model
  • FIG 7. Global Bioprocess Validation Market, pest analysis
  • FIG 8. Global Bioprocess Validation Market, value chain analysis
  • FIG 9. Global Bioprocess Validation Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Bioprocess Validation Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Bioprocess Validation Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Bioprocess Validation Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Bioprocess Validation Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Bioprocess Validation Market, regional snapshot 2019 & 2029
  • FIG 15. North America Bioprocess Validation Market2019 & 2029 (USD Million)
  • FIG 16. Europe Bioprocess Validation Market2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Bioprocess Validation Market2019 & 2029 (USD Million)
  • FIG 18. Latin America Bioprocess Validation Market2019 & 2029 (USD Million)
  • FIG 19. Global Bioprocess Validation Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!